19 HARTUM STREET, BYNET BUILDING, 3RD FL, Jerusalem, L3
Notice to Owners of Ordinary Shares
Announces Strategic Collaboration with Inland Psychiatry Medical Group
Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
Reports Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934 for the Month of September 2026
Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
Leading the Next Phase of Interventional Psychiatry Technology. Evidence. Scale. Growth.
Reports Second Quarter 2026 Financial Results and Operational Highlights
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Notice of Exempt Offering of Securities
No filings found
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
S-8 POS
Correspondence
Submission Upload